RESEARCH-USE BIOSIMILAR ANTIBODY
Cergutuzumab
Monoclonal antibody · IgG1
Cergutuzumab is a fully human IgG1 antibody that targets carcinoembryonic antigen (CEA, CEACAM5, CD66e). Cergutuzumab can be used to form the recombinant protein Cergutuzumab amunaleukin (HY-P99498).
TARGETCEA
YMonoclonal antibody
CATALOGSC-BS-685
CATALOG NUMBERSC-BS-685
MOLECULAR WEIGHTApprox. 145.595 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Cergutuzumab is a fully human IgG1 antibody that targets carcinoembryonic antigen (CEA, CEACAM5, CD66e). Cergutuzumab can be used to form the recombinant protein Cergutuzumab amunaleukin (HY-P99498).
Cergutuzumab is a recombinant research-use antibody directed against CEA.